Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new nomenclature recently proposed by a panel of international experts so that the entity is defined based on positive criteria and linked to pathogenesis, replacing the traditional non-alcoholic fatty liver disease (NAFLD), a definit...

Descripción completa

Detalles Bibliográficos
Autores principales: Fassio, Eduardo, Barreyro, Fernando J, Pérez, M Soledad, Dávila, Diana, Landeira, Graciela, Gualano, Gisela, Ruffillo, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891669/
https://www.ncbi.nlm.nih.gov/pubmed/35317172
http://dx.doi.org/10.4254/wjh.v14.i2.354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891669/
https://www.ncbi.nlm.nih.gov/pubmed/35317172
http://dx.doi.org/10.4254/wjh.v14.i2.354

Ejemplares similares